首页> 外文期刊>Applied biochemistry and biotechnology, Part A. enzyme engineering and biotechnology >Genome Shuffling and Ribosome Engineering of Streptomyces actuosus for High-Yield Nosiheptide Production
【24h】

Genome Shuffling and Ribosome Engineering of Streptomyces actuosus for High-Yield Nosiheptide Production

机译:产链霉菌的基因组改组和核糖体工程用于高产Nosiheptide的生产

获取原文
获取原文并翻译 | 示例
           

摘要

Nosiheptide is one of the EU-approved sulfur-containing peptides in feed industry to inhibit the growth of the majority of Gram-positive bacteria. The main purpose of this study is directed to breed the high nosiheptide-producers by genome shuffling and ribosome engineering in Streptomyces actuosus AW7. The starting population for shuffling was generated by combining ~(60)Coγ-irradiation with LiCl mutagenesis treatments on the spores. After four rounds of protoplast fusion exposed to streptomycin as adaptive pressure, a high-yield recombinant strain D92 was obtained. In a 10-L fermenter, nosiheptide production reached 1.54 g/L which was 9.20- fold compared to that of the parental strain. Hyphae development, metabolic process, and ribosomal protein S12 sequence were investigated to characterize the differentiation among the recombinants. Several mutations in S12 were believed to be responsible to streptomycin resistance in the tested strain. The results demonstrated that the combination of genome shuffling and ribosome engineering is an efficient approach to breed high-yield industrial strains.
机译:Nosiheptide是饲料行业中欧盟认可的一种含硫肽,可抑制大多数革兰氏阳性细菌的生长。这项研究的主要目的是通过基因组改组和核糖体工程在acteptomyces actuosus AW7中繁殖高Nosheptide生产者。通过将〜(60)Coγ射线辐照与对孢子的LiCl诱变处理相结合,产生了改组的起始种群。在暴露于链霉素作为适应性压力的四轮原生质体融合之后,获得了高产率的重组菌株D92。在10 L的发酵罐中,诺西肽的产量达到1.54 g / L,是亲本菌株的9.20倍。研究了菌丝发育,代谢过程和核糖体蛋白S12序列,以表征重组体之间的分化。据信S12中的几个突变与测试菌株中的链霉素抗性有关。结果表明,基因组改组和核糖体工程的结合是育种高产工业菌株的有效方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号